MedTrace Logo

Microneedles for Diagnosis of LTBI

NCT04552015 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2023-03-01

No results posted yet for this study

Summary

This study will evaluate new technique, microneedle, to detect latent tuberculosis (TB) in healthy volunteers

Conditions

  • Latent Tuberculosis

Interventions

DIAGNOSTIC_TEST

TST vs PPD microneedle test

TST vs First patch: 800 um in length, PPD1 formulation; Second patch: 1,500 um in length, PPD1 formulation; Third patch: 800 um in length, PPD2 formulation; and Fourth patch: 1,500 um in length, PPD2 formulation

Sponsors & Collaborators

  • National Nanotechnology Center (NANOTEC), The National Science and Technology Development Agency (NSTDA)

    collaborator UNKNOWN

  • The HIV Netherlands Australia Thailand Research Collaboration

    lead OTHER

Principal Investigators

  • Sivaporn Gatechompol, MD · The HIV Netherlands Australia Thailand Research Collaboration

  • Jeerapond Leelawattanachai, PhD · King Chulalongkorn Memorial Hospital

  • Saradee Warit, PhD · King Chulalongkorn Memorial Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-08
Primary Completion
2022-10-01
Completion
2022-10-01

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04552015 on ClinicalTrials.gov